Crestline Investors, Inc.
Insider CIK 1626596 · JUNO 10% owner · DNLI 10% owner · MDWT Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDWT MIDWEST HOLDING INC. | A Award | 2022-06-14 | 2022-06-16 | 2,674 | — | $0 | 447,845 | SEC↗ |
| MDWT MIDWEST HOLDING INC. | A Award | 2021-11-11 | 2021-11-15 | 727 | — | $0 | 445,171 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-02-12 | 2021-02-17 | 2,216,798 | $65.00 | $144.09M | 9,984,836 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-08-12 | 2020-08-14 | 1,443,247 | $31.65 | $45.68M | 12,201,634 | SEC↗ |
| MDWT MIDWEST HOLDING INC. | A Award deriv | 2020-07-31 | 2020-08-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-05 | 2020-06-09 | 1,922,855 | $25.75 | $49.51M | 13,644,881 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-02-26 | 2020-02-28 | 3,894,764 | $20.25 | $78.87M | 15,567,736 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 128,200 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 240,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 2,500,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 1,875,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 743,599 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 14,499,999 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 2,500,000 | — | $0 | 17,312,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 14,499,999 | — | $0 | 14,812,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 1,875,000 | — | $0 | 19,187,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 743,599 | — | $0 | 743,599 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 128,200 | — | $0 | 871,799 | SEC↗ |
| DNLI Denali Therapeutics Inc. | P Buy | 2017-12-12 | 2017-12-14 | 275,000 | $18.00 | $4.95M | 19,462,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 240,000 | — | $0 | 1,111,799 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2017-07-13 | 2017-07-17 | 8,000,000 | $27.00 | $216.00M | 9,166,130 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | S Sale | 2016-03-01 | 2016-03-03 | 8,600,000 | $39.00 | $335.40M | 17,166,130 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 8,750,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 13,750,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 68,395 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 1,250,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 2,277,732 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-24 | 1,250,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-24 | 68,395 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 2,277,732 | — | $0 | 25,766,130 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 68,395 | — | $0 | 1,318,395 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 13,750,000 | — | $0 | 14,738,398 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 8,750,000 | — | $0 | 23,488,398 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-24 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-24 | 68,395 | — | $0 | 1,318,395 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | P Buy | 2014-12-23 | 2014-12-24 | 625,000 | $24.00 | $15.00M | 988,398 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | P Buy | 2014-12-19 | 2014-12-23 | 625,000 | $25.00 | $15.63M | 988,398 | SEC↗ |